Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 6 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 10875855

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted
  2. US 10815239

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  3. US 10813929

    Treating cancer with ATR inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  4. US 10815225

    Antiproliferation compounds and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  5. US 10801076

    Influenza A virus variants

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  6. US 10800781

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted
  7. US 10793563

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  8. US 10793547

    Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  9. US 10787472

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  10. US 10786512

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  11. US 10787452

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted
  12. US 10766869

    Triazoles for the treatment of demyelinating dieases

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  13. US 10758534

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  14. US 10738030

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  15. US 10738027

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  16. US 10738009

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  17. US 10738305

    Materials and methods for treatment of hemoglobinopathies

    Vertex Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted
  18. US 10716789

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted
  19. US 10669298

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  20. US 10662192

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted May 26, 2020 · Expires May 21, 2040

    granted
  21. US 10654829

    Crystalline forms and compositions of CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted May 19, 2020 · Expires May 14, 2040

    granted
  22. US 10647661

    Carboxamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  23. US 10646481

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted
  24. US 10640501

    Methods of preparing inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 5, 2020 · Expires Apr 30, 2040

    granted